Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Understanding ExDividend Dates and Stock Prices A Case Study of Olin Corporation

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_Investment (5)
0
SHARES
15
VIEWS
Share on FacebookShare on Twitter

When a company like Olin Corporation goes ex-dividend, it signals a drop in stock price to account for the upcoming dividend payment. Olin recently declared a quarterly dividend of 20 cents per share, with the ex-dividend date set for Wednesday. Shareholders holding OLN until the end of Tuesday’s trading session will qualify for this dividend, which will be distributed on March 15, 2024.

Olin Corporation has a track record of issuing quarterly dividends, offering an annual dividend of $0.80 and a dividend yield of 1.52%. The company’s ex-dividend date is scheduled for March 6, 2024. Investors should pay close attention to ex-dividend dates to determine eligibility for dividends and how they may influence stock prices.

Olin Corporation (OLN) Stock Soars on Strong Performance and Positive Momentum

On March 1, 2024, Olin Corporation (OLN) had a strong performance in the stock market. According to data from CNN Money, OLN was trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well in the long term.

The price of OLN shares increased by $0.74 since the market last closed, representing a 1.38% rise. The stock opened at $53.86, which was $0.06 higher than its previous close. This opening price suggests that there was positive momentum for OLN at the start of the trading day.

Investors may have been drawn to OLN on March 1st due to its strong performance and positive price momentum. The fact that the stock was trading near its 52-week high and above its 200-day moving average could have signaled to investors that OLN was a strong investment opportunity.

Overall, Olin Corporation had a solid performance on March 1, 2024, with its stock price showing positive momentum and growth. Investors will continue to monitor OLN’s performance in the days ahead to see if this positive trend continues.

OLN Stock Financial Performance Declines in 2024: Revenue, Net Income, and EPS Drop Compared to Previous Year

On March 1, 2024, OLN stock experienced a decline in its financial performance compared to the previous year and the last quarter. According to data from CNN Money, OLN reported a total revenue of $6.83 billion for the past year, which represents a decrease of 27.12% compared to the previous year. Additionally, the total revenue for the last quarter was $1.61 billion, reflecting a decrease of 3.4% since the previous quarter.

In terms of net income, OLN reported a net income of $460.20 million for the past year, indicating a decrease of 65.32% compared to the previous year. The net income for the last quarter was $52.90 million, representing a decrease of 49.18% since the previous quarter.

Furthermore, the earnings per share (EPS) for OLN were $3.57 for the past year, showing a decrease of 60.01% compared to the previous year. The EPS for the last quarter was $0.43, reflecting a decrease of 47.75% since the previous quarter.

Overall, the financial performance of OLN stock on March 1, 2024, indicates a decline in total revenue, net income, and earnings per share compared to the previous year and the last quarter. Investors and analysts may need to closely monitor the company’s performance and financial health to assess its future prospects and potential for growth.

Tags: OLN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Charts for stock trading

Insperity Announces ExDividend Date and Quarterly Payout for Shareholders

Fresh Del Monte Produce to Pay Quarterly Dividend on March 29 2024

Pfizer Receives Overweight Rating and 45 Price Target from Cantor Fitzgerald Analyst

Recommended

FITB stock news

Davenport & Co LLC Boosts Stake in Starwood Property Trust, Inc.: A Resilient REIT Positioned for Growth

3 years ago
AT&T Stock

AT&T Bets Big on Network Transformation with Massive Infrastructure Push

5 months ago
Dominion Energy Stock

Dominion Energy Faces Critical Earnings Test Amid Diverging Metrics

3 months ago
Riot Blockchain Stock

Riot Blockchain Stock: Riding the Bitcoin Mining Momentum

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

Fossil Group Stock Surges Past Key Technical Threshold

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report

by Dieter Jaworski
February 5, 2026
0

Shares of Viking Therapeutics are trading within a consolidated range as the market anticipates significant corporate news....

Solana Stock

Solana Faces Billions in Potential Token Supply Releases

February 5, 2026
CureVac Stock

CureVac Delisted Following BioNTech Acquisition Completion

February 5, 2026
EOS Stock

Strategic Robotics Partnership Signals New Growth Phase for EOS Defence

February 5, 2026
NexPoint Residential Stock

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: Investors Await Key Clinical Updates in Forthcoming Report
  • Solana Faces Billions in Potential Token Supply Releases
  • CureVac Delisted Following BioNTech Acquisition Completion

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com